Sobrera Pharma AB is pleased to announce the Decisions to Grant on the European patent 3582764 titled ’Treatment of Alcohol Use’ by the European Patent Office (EPO). The decision to grant on the patent provides a protection of our drug candidate SO-001 for use in treating alcohol use disorder (AUD) and/or treating alcohol risk consumption.

Read More